 | • レポートコード：MRC2-11QY12149 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血液疾患診断・治療のグローバル市場について調査・分析したレポートです。種類別（薬剤、物質）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血液疾患診断・治療の競争状況、市場シェア ・世界の血液疾患診断・治療市場：種類別市場規模 2015年-2020年（薬剤、物質） ・世界の血液疾患診断・治療市場：種類別市場規模予測 2021年-2026年（薬剤、物質） ・世界の血液疾患診断・治療市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の血液疾患診断・治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の血液疾患診断・治療市場分析：米国、カナダ ・ヨーロッパの血液疾患診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血液疾患診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血液疾患診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血液疾患診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Amgen、Baxter Healthcare Corporation、Bayer Healthcare Pharmaceuticals、Biogen Idec、Bristol-Myers Squibb、C.R. Bard、Eli Lilly、GE Healthcare、GlaxoSmithKline、Pfizer、Sanofi、Siemens、Teva Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting processes. People can be affected by many different types of blood disorders.
Market Analysis and Insights: Global Hematological Disorders Diagnostic and Therapeutic Market
The global Hematological Disorders Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hematological Disorders Diagnostic and Therapeutic Scope and Market Size
Hematological Disorders Diagnostic and Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hematological Disorders Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Amgen
Baxter Healthcare Corporation
Bayer Healthcare Pharmaceuticals
Biogen Idec
Bristol-Myers Squibb
C.R. Bard
Eli Lilly
GE Healthcare
GlaxoSmithKline
Pfizer
Sanofi
Siemens
Teva Pharmaceutical
Market segment by Type, the product can be split into
Drug
Physical
Market segment by Application, split into
Hospital
Clinic
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hematological Disorders Diagnostic and Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Hematological Disorders Diagnostic and Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug
1.4.3 Physical
1.5 Market by Application
1.5.1 Global Hematological Disorders Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hematological Disorders Diagnostic and Therapeutic Market Perspective (2015-2026)
2.2 Global Hematological Disorders Diagnostic and Therapeutic Growth Trends by Regions
2.2.1 Hematological Disorders Diagnostic and Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hematological Disorders Diagnostic and Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hematological Disorders Diagnostic and Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Hematological Disorders Diagnostic and Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hematological Disorders Diagnostic and Therapeutic Players by Market Size
3.1.1 Global Top Hematological Disorders Diagnostic and Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Hematological Disorders Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hematological Disorders Diagnostic and Therapeutic Market Concentration Ratio
3.2.1 Global Hematological Disorders Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hematological Disorders Diagnostic and Therapeutic Revenue in 2019
3.3 Hematological Disorders Diagnostic and Therapeutic Key Players Head office and Area Served
3.4 Key Players Hematological Disorders Diagnostic and Therapeutic Product Solution and Service
3.5 Date of Enter into Hematological Disorders Diagnostic and Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hematological Disorders Diagnostic and Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
5.2 Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hematological Disorders Diagnostic and Therapeutic Market Size (2015-2020)
6.2 Hematological Disorders Diagnostic and Therapeutic Key Players in North America (2019-2020)
6.3 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020)
6.4 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hematological Disorders Diagnostic and Therapeutic Market Size (2015-2020)
7.2 Hematological Disorders Diagnostic and Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020)
7.4 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Hematological Disorders Diagnostic and Therapeutic Market Size (2015-2020)
8.2 Hematological Disorders Diagnostic and Therapeutic Key Players in China (2019-2020)
8.3 China Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020)
8.4 China Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hematological Disorders Diagnostic and Therapeutic Market Size (2015-2020)
9.2 Hematological Disorders Diagnostic and Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020)
9.4 Japan Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Size (2015-2020)
10.2 Hematological Disorders Diagnostic and Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Hematological Disorders Diagnostic and Therapeutic Market Size (2015-2020)
11.2 Hematological Disorders Diagnostic and Therapeutic Key Players in India (2019-2020)
11.3 India Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020)
11.4 India Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hematological Disorders Diagnostic and Therapeutic Market Size (2015-2020)
12.2 Hematological Disorders Diagnostic and Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Hematological Disorders Diagnostic and Therapeutic Introduction
13.1.4 Abbott Laboratories Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Hematological Disorders Diagnostic and Therapeutic Introduction
13.2.4 Amgen Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Baxter Healthcare Corporation
13.3.1 Baxter Healthcare Corporation Company Details
13.3.2 Baxter Healthcare Corporation Business Overview
13.3.3 Baxter Healthcare Corporation Hematological Disorders Diagnostic and Therapeutic Introduction
13.3.4 Baxter Healthcare Corporation Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.3.5 Baxter Healthcare Corporation Recent Development
13.4 Bayer Healthcare Pharmaceuticals
13.4.1 Bayer Healthcare Pharmaceuticals Company Details
13.4.2 Bayer Healthcare Pharmaceuticals Business Overview
13.4.3 Bayer Healthcare Pharmaceuticals Hematological Disorders Diagnostic and Therapeutic Introduction
13.4.4 Bayer Healthcare Pharmaceuticals Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.4.5 Bayer Healthcare Pharmaceuticals Recent Development
13.5 Biogen Idec
13.5.1 Biogen Idec Company Details
13.5.2 Biogen Idec Business Overview
13.5.3 Biogen Idec Hematological Disorders Diagnostic and Therapeutic Introduction
13.5.4 Biogen Idec Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.5.5 Biogen Idec Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Hematological Disorders Diagnostic and Therapeutic Introduction
13.6.4 Bristol-Myers Squibb Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 C.R. Bard
13.7.1 C.R. Bard Company Details
13.7.2 C.R. Bard Business Overview
13.7.3 C.R. Bard Hematological Disorders Diagnostic and Therapeutic Introduction
13.7.4 C.R. Bard Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.7.5 C.R. Bard Recent Development
13.8 Eli Lilly
13.8.1 Eli Lilly Company Details
13.8.2 Eli Lilly Business Overview
13.8.3 Eli Lilly Hematological Disorders Diagnostic and Therapeutic Introduction
13.8.4 Eli Lilly Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.8.5 Eli Lilly Recent Development
13.9 GE Healthcare
13.9.1 GE Healthcare Company Details
13.9.2 GE Healthcare Business Overview
13.9.3 GE Healthcare Hematological Disorders Diagnostic and Therapeutic Introduction
13.9.4 GE Healthcare Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.9.5 GE Healthcare Recent Development
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Details
13.10.2 GlaxoSmithKline Business Overview
13.10.3 GlaxoSmithKline Hematological Disorders Diagnostic and Therapeutic Introduction
13.10.4 GlaxoSmithKline Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
13.10.5 GlaxoSmithKline Recent Development
13.11 Pfizer
10.11.1 Pfizer Company Details
10.11.2 Pfizer Business Overview
10.11.3 Pfizer Hematological Disorders Diagnostic and Therapeutic Introduction
10.11.4 Pfizer Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
10.11.5 Pfizer Recent Development
13.12 Sanofi
10.12.1 Sanofi Company Details
10.12.2 Sanofi Business Overview
10.12.3 Sanofi Hematological Disorders Diagnostic and Therapeutic Introduction
10.12.4 Sanofi Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
10.12.5 Sanofi Recent Development
13.13 Siemens
10.13.1 Siemens Company Details
10.13.2 Siemens Business Overview
10.13.3 Siemens Hematological Disorders Diagnostic and Therapeutic Introduction
10.13.4 Siemens Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
10.13.5 Siemens Recent Development
13.14 Teva Pharmaceutical
10.14.1 Teva Pharmaceutical Company Details
10.14.2 Teva Pharmaceutical Business Overview
10.14.3 Teva Pharmaceutical Hematological Disorders Diagnostic and Therapeutic Introduction
10.14.4 Teva Pharmaceutical Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020)
10.14.5 Teva Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hematological Disorders Diagnostic and Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Hematological Disorders Diagnostic and Therapeutic Revenue
Table 3. Ranking of Global Top Hematological Disorders Diagnostic and Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hematological Disorders Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug
Table 6. Key Players of Physical
Table 7. Global Hematological Disorders Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hematological Disorders Diagnostic and Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hematological Disorders Diagnostic and Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions (2015-2020)
Table 11. Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hematological Disorders Diagnostic and Therapeutic Market Growth Strategy
Table 17. Main Points Interviewed from Key Hematological Disorders Diagnostic and Therapeutic Players
Table 18. Global Hematological Disorders Diagnostic and Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Players (2015-2020)
Table 20. Global Top Hematological Disorders Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematological Disorders Diagnostic and Therapeutic as of 2019)
Table 21. Global Hematological Disorders Diagnostic and Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hematological Disorders Diagnostic and Therapeutic Product Solution and Service
Table 24. Date of Enter into Hematological Disorders Diagnostic and Therapeutic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hematological Disorders Diagnostic and Therapeutic Market Size Share by Type (2015-2020)
Table 28. Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Type (2021-2026)
Table 29. Global Hematological Disorders Diagnostic and Therapeutic Market Size Share by Application (2015-2020)
Table 30. Global Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hematological Disorders Diagnostic and Therapeutic Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hematological Disorders Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hematological Disorders Diagnostic and Therapeutic Market Share (2019-2020)
Table 34. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 36. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 38. Europe Key Players Hematological Disorders Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hematological Disorders Diagnostic and Therapeutic Market Share (2019-2020)
Table 40. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 42. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 44. China Key Players Hematological Disorders Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hematological Disorders Diagnostic and Therapeutic Market Share (2019-2020)
Table 46. China Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 47. China Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 48. China Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 49. China Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 50. Japan Key Players Hematological Disorders Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hematological Disorders Diagnostic and Therapeutic Market Share (2019-2020)
Table 52. Japan Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 54. Japan Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hematological Disorders Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hematological Disorders Diagnostic and Therapeutic Market Share (2019-2020)
Table 58. Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 60. Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 62. India Key Players Hematological Disorders Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hematological Disorders Diagnostic and Therapeutic Market Share (2019-2020)
Table 64. India Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 65. India Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 66. India Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 67. India Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hematological Disorders Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hematological Disorders Diagnostic and Therapeutic Market Share (2019-2020)
Table 70. Central & South America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 72. Central & South America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Product
Table 82. Amgen Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 83. Amgen Recent Development
Table 84. Baxter Healthcare Corporation Company Details
Table 85. Baxter Healthcare Corporation Business Overview
Table 86. Baxter Healthcare Corporation Product
Table 87. Baxter Healthcare Corporation Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 88. Baxter Healthcare Corporation Recent Development
Table 89. Bayer Healthcare Pharmaceuticals Company Details
Table 90. Bayer Healthcare Pharmaceuticals Business Overview
Table 91. Bayer Healthcare Pharmaceuticals Product
Table 92. Bayer Healthcare Pharmaceuticals Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 93. Bayer Healthcare Pharmaceuticals Recent Development
Table 94. Biogen Idec Company Details
Table 95. Biogen Idec Business Overview
Table 96. Biogen Idec Product
Table 97. Biogen Idec Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 98. Biogen Idec Recent Development
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Product
Table 102. Bristol-Myers Squibb Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. C.R. Bard Company Details
Table 105. C.R. Bard Business Overview
Table 106. C.R. Bard Product
Table 107. C.R. Bard Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 108. C.R. Bard Recent Development
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Product
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 113. Eli Lilly Recent Development
Table 114. GE Healthcare Company Details
Table 115. GE Healthcare Business Overview
Table 116. GE Healthcare Product
Table 117. GE Healthcare Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 118. GE Healthcare Recent Development
Table 119. GlaxoSmithKline Company Details
Table 120. GlaxoSmithKline Business Overview
Table 121. GlaxoSmithKline Product
Table 122. GlaxoSmithKline Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline Recent Development
Table 124. Pfizer Company Details
Table 125. Pfizer Business Overview
Table 126. Pfizer Product
Table 127. Pfizer Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 128. Pfizer Recent Development
Table 129. Sanofi Company Details
Table 130. Sanofi Business Overview
Table 131. Sanofi Product
Table 132. Sanofi Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 133. Sanofi Recent Development
Table 134. Siemens Company Details
Table 135. Siemens Business Overview
Table 136. Siemens Product
Table 137. Siemens Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 138. Siemens Recent Development
Table 139. Teva Pharmaceutical Company Details
Table 140. Teva Pharmaceutical Business Overview
Table 141. Teva Pharmaceutical Product
Table 142. Teva Pharmaceutical Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 143. Teva Pharmaceutical Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Drug Features
Figure 3. Physical Features
Figure 4. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Hematological Disorders Diagnostic and Therapeutic Report Years Considered
Figure 8. Global Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions: 2020 VS 2026
Figure 10. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Players in 2019
Figure 13. Global Top Hematological Disorders Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematological Disorders Diagnostic and Therapeutic as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Hematological Disorders Diagnostic and Therapeutic Revenue in 2019
Figure 15. North America Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
クローン病診断・治療の世界市場（～2026年） Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any part of the gastrointestinal tract from mouth to anus. Signs and symptoms often include abdominal pain, diarrhea, fever, and weight loss. As the prevalence of the disease increases, it is expected to drive the Crohn's …- 血液悪性腫瘍の世界市場（～2026年） Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Market Analysis and Insights: Global Hematological Malignancies Market The global Hematological Malignancies market size is projected to reach …
- 非血液がんの世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 治療用血漿交換の世界市場（～2026年） Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely…